Sage Mountain Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,397
Closed -$518K 457
2025
Q4
$518K Sell
5,397
-2,142
-28% -$208K 0.03% 264
2025
Q3
$718K Buy
7,539
+4,280
+131% +$393K 0.04% 207
2025
Q2
$284K Buy
3,259
+298
+10% +$25.3K 0.02% 342
2025
Q1
$266K Buy
+2,961
New +$265K 0.02% 325
2024
Q4
Sell
-2,847
Closed -$256K 503
2024
Q3
$256K Buy
2,847
+178
+7% +$15K 0.02% 321
2024
Q2
$210K Buy
+2,669
New +$219K 0.02% 327
2023
Q4
Sell
-3,275
Closed -$257K 370
2023
Q3
$257K Sell
3,275
-274
-8% -$22.9K 0.04% 206
2023
Q2
$313K Buy
3,549
+224
+7% +$19.3K 0.04% 173
2023
Q1
$268K Buy
+3,325
New +$271K 0.04% 183
2022
Q2
Sell
-2,574
Closed -$286K 628
2022
Q1
$286K Sell
2,574
-1,828
-42% -$193K 0.04% 394
2021
Q4
$455K Sell
4,402
-601
-12% -$69.6K 0.05% 329
2021
Q3
$627K Buy
5,003
+983
+24% +$127K 0.09% 214
2021
Q2
$499K Buy
4,020
+1,932
+93% +$243K 0.08% 229
2021
Q1
$247K Buy
+2,088
New +$245K 0.05% 265

Other funds holding MDT

Sage Mountain Advisors's MDT Position: Q1 2026 in Review

Sage Mountain Advisors sold out of Medtronic (MDT) in Q1 2026, closing a stake of 5,397 shares — an estimated $518K sold.

Sage Mountain Advisors first reported a position in MDT in Q1 2021 and held it in 14 quarters. The position peaked at $718K in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Sage Mountain Advisors reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Sage Mountain Advisors sold 5,397 Medtronic shares in Q1 2026, an estimated $518K.
  • Sage Mountain Advisors first reported a position in Medtronic in Q1 2021 and held it in 14 quarters.
  • Sage Mountain Advisors's Medtronic position peaked at $718K in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Sage Mountain Advisors's 13F filing for Q1 2026, filed 11 May 2026.